MUN — Munar Pharma SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN15.31m
- PLN13.91m
- PLN0.25m
Annual cashflow statement for Munar Pharma SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.03 | -0.31 | -3.58 | 0.115 | -0.756 |
| Depreciation | |||||
| Non-Cash Items | -0.127 | 0.368 | 0.015 | -0.716 | 0.012 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.532 | -0.321 | 3.6 | -0.543 | -0.402 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -1.68 | -0.258 | 0.06 | -1.13 | -1.15 |
| Capital Expenditures | — | -0.107 | — | — | -0.007 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.073 | 0 | — | 0.776 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.073 | -0.107 | — | 0.776 | -0.007 |
| Financing Cash Flow Items | 0.017 | -0.241 | -0.205 | 0.246 | -0.171 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.05 | 0.127 | -0.044 | 0.205 | 2.79 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.295 | -0.238 | 0.016 | -0.148 | 1.64 |